# NASONEX 24HR ALLERGY
> **NDA215712** · New Drug Application · Sponsor: PERRIGO PHARMA INTL · Approved 2022-03-17
## Drug
- **FDA Application Number:** NDA215712
- **Application type:** New Drug Application
- **Brand name:** NASONEX 24HR ALLERGY
- **Generic name:** MOMETASONE FUROATE
- **Active ingredients:** MOMETASONE FUROATE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Over-the-counter
- **Sponsor:** PERRIGO PHARMA INTL
- **Manufacturer:** Rugby Laboratories
- **First approval:** 2022-03-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215712)
---
*MORVS · CC0 1.0*